Fresenius Medical Care AG

FME

DE0005785802

Healthcare Facilities & Services

Market Closed - Xetra Other stock markets 16:35:12 17/07/2024 BST			After market 20:59:27
36.3 ^EUR	+0.69%		36.4	+0.28%

07-16	Fresenius rises - Deutsche Bank: higher annual targets possible	DP
07-16	Frankfurt shares open: Political uncertainty weighs on Dax	DP

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Sell rating from JP Morgan

January 17, 2022 at 01:33 pm

The analyst from JP Morgan, David Adlington, maintains his advice to sell. The target price remains unchanged at EUR 48.70.

Latest news about Fresenius Medical Care AG

Fresenius rises - Deutsche Bank: higher annual targets possible	07-16	DP
Frankfurt shares open: Political uncertainty weighs on Dax	07-16	DP
US FTC probing DaVita, Fresenius Medical, Politico reports	07-13	RE
FRESENIUS MEDICAL CARE : Still a long way to go	07-12
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Receives a Buy rating from Goldman Sachs	07-05	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : UBS sticks Neutral	06-19	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from Jefferies	06-14	ZD
Transcript : Fresenius Medical Care AG - Special Call	06-13
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading	06-12	MT
Fresenius Signs Agreements With Wind, Solar Energy Project Developers in US, Germany	06-12	MT
AbbVie's tight grip on Humira market raises concerns about biosimilars	06-07	RE
Optimism gives Dax a tailwind	06-06	RE
Dpa-AFX Overview: COMPANIES from 05.06.2024 - 15:15	06-05	DP
Fresenius raises targets for hospital business - shares up	06-05	DP
Fresenius raises the bar for hospital subsidiary Helios	06-05	RE
Fresenius driven by higher Helios targets	06-05	DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Goldman Sachs keeps its Buy rating	06-05	ZD
Fresenius lifts 2024 targets for private healthcare unit Helios	06-05	RE
Fresenius chart breakout fails before capital market day	06-04	DP
Austria's state holding ÖBAG sells stake in Vamed to Fresenius	06-04	RE
FMC briefly burdened by research success in the fight against diabetes	05-28	DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Berenberg reaffirms its Buy rating	05-28	ZD
European Equities Traded in the US as American Depositary Receipts Trend Higher Friday, End Week Marginally Lower	05-24	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan remains a Sell rating	05-24	ZD
FMC, Fresenius and Davita rise after Ozempic news	05-24	DP

Chart Fresenius Medical Care AG

Duration

Period

More charts

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

Sector

Healthcare Facilities & Services

Calendar

29/07/2024 - Q2 2024 Earnings Call

Related indices

STOXX EUROPE 600 (EUR) , MDAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

FRESENIUS MEDICAL CARE : Still a long way to go

July 12, 2024 at 10:02 am

More Strategies

Ratings for Fresenius Medical Care AG

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

36.05 EUR

Average target price

40 EUR

Spread / Average Target

+10.96%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
FRESENIUS MEDICAL CARE AG	-4.37%	11.51B
HCA HEALTHCARE, INC.	+19.32%	83.53B
CVS HEALTH CORPORATION	-21.99%	75.4B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+2.32%	26.73B
LABCORP HOLDINGS INC.	-5.06%	18.25B
FRESENIUS SE & CO. KGAA	+6.95%	18.12B
QUEST DIAGNOSTICS INCORPORATED	+7.69%	16.51B
NATERA, INC.	+76.20%	14.05B
TENET HEALTHCARE CORPORATION	+76.56%	13.03B
PURE HEALTH HOLDING	-27.89%	12.67B

Other Healthcare Facilities & Services

Fresenius Medical Care AG

Equities

FME

DE0005785802

Healthcare Facilities & Services

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Sell rating from JP Morgan

EPS Revisions